In this report, Bio Green Med Solution, BGMS, the Company, we, us, and our refer to Bio Green Med Solution, Inc. ( fka Cyclacel Pharmaceuticals, Inc.). Recent Developments Equity Transactions In December 2024, Bio Green Med Solution, Inc. ( BGMS or the Company ), a Delaware corporation formerly known as Cyclacel Pharmaceuticals, Inc., announced that it was in the process of exploring and review…
Revenue declined 100.0% YoY. The question is whether this is cyclical or a structural shift.
Negative free cash flow of -$5M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (FY)
$0.00
▼ -100.0% YoY
Net Income (TTM)
-$3M
▲ +73.3% YoY
Op. Margin
—
ROIC
-57.83%
▲ +2728.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$2M
▲ +40.3% YoY
Op. Cash Flow (TTM)
-$2M
▲ +40.3% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$3M
Continue Research